Showing posts with label asthmatic. Show all posts
Showing posts with label asthmatic. Show all posts

Friday, September 27, 2013

0 IL-17-producing peripheral blood CD117+ neutrophils increase in allergic asthmatic subjects

Open Access


Research


IL-17-producing peripheral blood CD117+ neutrophils increase in allergic asthmatic subjects



Carlos Ramirez-Velazquez, Elena Cristina Castillo, Leopoldo Guido-Bayardo and Vianney Ortiz-Navarrete










For all author emails, please log on.








Allergy, Asthma & Clinical Immunology 2013, 9:23 doi:10.1186/1710-1492-9-23

Published: 3 July 2013





Abstract (provisional)


Background


A T helper cell (TH) 17-biased response has been observed in patients with allergic asthma, particularly in those with neutrophil accumulation in the lung. Therefore, we sought to test the hypothesis that neutrophils might be an important source of interleukin (IL)-17 in allergic asthma.

Methods


Whole peripheral blood cells from non-asthmatic control subjects (n = 17) and patients with mild asthma (n = 7), moderate but persistent asthma (n = 4), or acute asthma (n = 6) were analyzed for IL-17A expression in CD177+ neutrophils. IL-17A expression was also analyzed in CD3+CD4+ and CD3+CD8+ lymphocyte populations. Asthmatic patients were classified as allergic to fungi, indoor allergens, or other allergens (e.g., pollen) based on a positive intradermal allergy test reaction.

Results


The percentage of CD177+ neutrophils in whole blood of asthmatic patients was higher than in healthy controls and highest in the moderate asthma group. Furthermore, the percentage of CD177+IL-17+ neutrophils was elevated in patients with mild asthma, whereas the CD4+ IL-17+ lymphocyte population was higher in asthmatic patients and highest in those with moderate but persistent asthma. We also found that the four patients that were allergic to fungi had the highest percentage of CD177+IL17+ neutrophils and CD8+IL17+ lymphocytes.

Conclusion


IL17+CD177+ Neutrophils increase in allergic asthma patients especially when allergic to fungi. This cell population, through release of IL-17, might be contributing during the initial phase asthmatic disease and/or during disease progression but its role has not yet been established






The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.



Wednesday, September 25, 2013

0 Factors affecting readmission for acute asthmatic attacks in children.















Factors affecting readmission for acute asthmatic attacks in children



Nualanong Visitsunthorn, Weerapong Lilitwat, Orathai Jirapongsananuruk, Pakit Vichyanond



Abstract




Background: Readmission following acute asthmatic attack has an impact on children’s quality of life and the cost of hospitalization. The objective of this study was to define the risk factors associated with readmission following acute asthmatic attacks in children

Methods: This is a retrospective case-control study in children who were admitted because of acute asthmatic attacks at the Department of Pediatrics, Siriraj Hospital, Mahidol University, Bangkok, Thailand. The admissions were classified into 2 groups, admission and readmission within one-month to one-year after the first admission. The medical records were reviewed and the factors that might affect readmission were evaluated.

Conclusion: A history of ICU admission at the first admission and the level of asthma control (partly controlled and uncontrolled according to Global of Initiative for Asthma guideline) increased the chances of readmission while influenza vaccination reduced the chances of readmission.Results: Seventy six children, 49 males and 27 females, were included. There were 56 children who were admitted only once and 20 children who were readmitted. The 1-year readmission rate for children with asthma was 26.3 %. The risk factors which made readmission more likely were a parental history of allergic disease (Odd Ratio, OR, = 3.17; 95% CI 1.10-9.10), a history of Intensive Care Unit (ICU) admission (OR 29.62; 95% CI 3.35-262.18),  methylprednisolone usage during the 1st admission (OR 8.33; 95% CI 2.46-28.19) and the level of asthma control. Increased risk of readmission was found in partly controlled asthma (OR 4.83; 95%CI 1.24-18.88) and uncontrolled asthma (OR 29; 95%CI 2.25-373.77).  The factor that decreased the chances of
readmission was a history of influenza vaccination (OR 0.24; 95% CI 0.16-0.36).




Full Text: PDF 


Friday, September 13, 2013

0 DNA Methylation Profiles of Airway Epithelial Cells and PBMCs from Healthy, Atopic and Asthmatic Children


Open Access

RESEARCH ARTICLE


DNA Methylation Profiles of Airway Epithelial Cells and PBMCs from Healthy, Atopic and Asthmatic Children







Dorota Stefanowicz1, Tillie-Louise Hackett1,2, Farshid S. Garmaroudi1, Oliver P. Günther3, Sarah Neumann4, Erika N. Sutanto5,7, Kak-Ming Ling7, Michael S. Kobor4, Anthony Kicic5,6,7, Stephen M. Stick5,6,7, Peter D. Paré1,8, Darryl A. Knight1,2*

1 James Hogg Research Centre at the Heart and Lung Institute, Department of Medicine, University of British Columbia and St. Paul’s Hospital, Vancouver, British Columbia, Canada, 2 Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada,3 Prevention of Organ Failure Centre of Excellence, Vancouver, British Columbia, Canada, 4 Department of Medical Genetics Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada, 5 Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, Western Australia, Australia, 6 School of Paediatrics and Child Health, University of Western Australia, Nedlands, Western Australia, Australia, 7 Telethon Institute for Child Health Research and Centre for Child Health Research, University of Western Australia, Nedlands, Western Australia, Australia, 8 Respiratory Division, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada


Abstract Top


Background


Allergic inflammation is commonly observed in a number of conditions that are associated with atopy including asthma, eczema and rhinitis. However, the genetic, environmental or epigenetic factors involved in these conditions are likely to be different. Epigenetic modifications, such as DNA methylation, can be influenced by the environment and result in changes to gene expression.

Objectives


To characterize the DNA methylation pattern of airway epithelial cells (AECs) compared to peripheral blood mononuclear cells (PBMCs) and to discern differences in methylation within each cell type amongst healthy, atopic and asthmatic subjects.

Methods


PBMCs and AECs from bronchial brushings were obtained from children undergoing elective surgery for non-respiratory conditions. The children were categorized as atopic, atopic asthmatic, non-atopic asthmatic or healthy controls. Extracted DNA was bisulfite treated and 1505 CpG loci across 807 genes were analyzed using the Illumina GoldenGate Methylation Cancer Panel I. Gene expression for a subset of genes was performed using RT-PCR.

Results


We demonstrate a signature set of CpG sites that are differentially methylated in AECs as compared to PBMCs regardless of disease phenotype. Of these, 13 CpG sites were specific to healthy controls, 8 sites were only found in atopics, and 6 CpGs were unique to asthmatics. We found no differences in the methylation status of PBMCs between disease phenotypes. In AECs derived from asthmatics compared to atopics, 8 differentially methylated sites were identified including CpGs in STAT5A and CRIP1. We demonstrate STAT5A gene expression is decreased whereas CRIP1 gene expression is elevated in the AECs from asthmatic compared to both healthy and atopic subjects.

Discussion


We characterized a cell specific DNA methylation signature for AECs compared to PBMCs regardless of asthmatic or atopic status. Our data highlight the importance of understanding DNA methylation in the epithelium when studying the epithelial contribution to asthma.



Tuesday, September 10, 2013

0 Obesity increases eosinophil activity in asthmatic children and adolescents.

Open Access


Research article


Obesity increases eosinophil activity in asthmatic children and adolescents



Milena B Grotta1*, Dalize M Squebola-Cola2, Adyleia ADC Toro1, Maria Angela GO Ribeiro1,Silvia B Mazon1, Jose D Ribeiro1 and Edson Antunes2








1Paediatric, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil

2Pharmacology Department, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil


For all author emails, please log on.








BMC Pulmonary Medicine 2013, 13:39 doi:10.1186/1471-2466-13-39



The electronic version of this article is the complete one and can be found online at:http://www.biomedcentral.com/1471-2466/13/39

















Received:1 November 2012
Accepted:10 June 2013
Published:18 June 2013


© 2013 Grotta et al.; licensee BioMed Central Ltd. 

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.







Abstract



Background


A clear relationship between asthma and obesity has been reported, but the mechanisms remain unclear. The aim of this study was to evaluate the influence of obesity on eosinophil activity (chemotaxis and adhesion) in asthmatic children and adolescents compared with cells from healthy volunteers.

Methods


Asthmatic obese (AO), asthmatic non-obese (ANO), non-asthmatic obese (NAO) and non-asthmatic non-obese (NANO) individuals were included in the present study. The chemotaxis of eosinophils after stimulation with eotaxin (300 ng/ml), platelet-activating factor (10 μM; PAF) and RANTES (100 ng/ml) was performed using a microchemotaxis chamber. The eosinophil peroxidase activity was measured to determine the adhesion activity of eosinophils cultivated on fibronectin-coated plates. The serum leptin, adiponectin, TNF-α and IgE levels were quantified using ELISA assays.

Results


The serum IgE levels and eosinophil counts were significantly higher in asthmatic (obese and non-obese) individuals compared with non-asthmatic individuals (obese and non-obese). Spontaneous eosinophil chemotaxis was greater in the AO group compared with either the ANO or NANO groups. The activation of eosinophils using eotaxin and PAF increased eosinophil chemotaxis in the AO group. RANTES treatment increased eosinophil chemotaxis in the NAO group compared with the NANO or ANO groups. The activation of eosinophils using eotaxin significantly increased eosinophil adhesion in the AO group compared with other groups. The serum leptin and TNF-α levels were higher in obese subjects (asthmatic and non-asthmatic), whereas the levels of adiponectin did not significantly differ among these groups.

Conclusion


This study is the first to show increased eosinophilic activity (chemotaxis and adhesion) associated with high serum leptin and TNF-α levels in atopic asthmatic obese children and adolescents compared with non-obese healthy volunteers.

Viewing options